Pharmaceutical giant Novo Nordisk recently conducted a large-scale study investigating whether weight-loss drug semaglutide could slow Alzheimers progression
2020 Jan 27;12(2):100 Protective effect of curcumin against ultraviolet A irradiationinduced photoaging in human dermal fibroblasts
Adults with obesity, metabolic syndrome, insulin resistance or significant difficulty losing weight despite lifestyle changes may be candidates for medically supervised peptide therapy
There's quite a few studies that show that
Stable drug levels throughout the week mean more consistent appetite suppression, more even blood sugar control, and fewer peaks and valleys in how the medication affects you day to day
They're marketed as being cheaper, easier to use, and available to anyone, unlike prescription weight loss injections, which require a consultation and have specific eligibility criteria